Latest filing published 23 Sept 2026 for CLINUVEL PHARMACEUTICALS LIMITED.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
listed in Annexure A): trading record in brief
listed in Annexure A) discloses dealings in Clinuvel Pharmaceuticals Limited to ASX. The record holds 2 filings, for trades running from 10 August 2026 to 18 September 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 23 September 2026, the filings show a transaction in Clinuvel Pharmaceuticals Limited. Source: insider filings from ASX. Past trades are no guide to future returns.
Companies and markets linked to listed in Annexure A)
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- ShareASXISIN AU000000CUV3ASX:2924-03139005-3A702403
- ShareASXASX:2924-03120996-3A698782
2 of 2 declarations